The European Union Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that were approved in the European Union …

A phase II study of pemigatinib plus durvalumab (MEDI4736) in previously treated advanced intrahepatic cholangiocarcinoma patients with FGFR-2 fusion or rearrangement

Feb 28, 2025 · Study Overview Brief Summary For advanced unresectable intrahepatic cholangiocarcinoma and gallbladder cancer, the current standard first-line treatment is a …

This study is a single-arm, open-arm, single-center clinical study to explore the efficacy and safety of HAIC in combination with Surufatinib and Toripalimab in patients with inoperable or …

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder …

Are you a health care provider looking for information on the clinical trials for cholangiocarcinoma (CCA)? Read more here.

Learn about new research and clinical trials for advanced intrahepatic cholangiocarcinoma. Discover new treatment options and find active studies.

Sep 27, 2024 · This study represents one of the longest follow-up periods reported of a prospective phase II trial along with one of the largest retrospective cohorts for patients with …

Listed here are the clinical trials for those with cholangiocarcinoma (bile duct cancer) or gall bladder cancer, currently open and recruiting in the UK. Wherever possible links for further …

In this landmark series review, we highlight the critical studies that have defined the surgical management of ICC, as well as several randomized controlled trials that have investigated …